Start Date
August 31, 2013
Primary Completion Date
August 31, 2014
Study Completion Date
March 31, 2015
Placebo
Active drug
ISBEM, São Paulo
Lead Sponsor
Ache Laboratorios Farmaceuticos S.A.
INDUSTRY